Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Effects on fertility

Effect on fertility: via oral route
Endpoint conclusion:
no study available
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

No studies were located regarding fertility impairment in human or animals after exposure to 4,4´-methylenedianiline by any route.

According to regulation 1907/2006/EC, annex 10, section 8.7 fertility studies are not required as MDA is a genotoxic carcinogen and appropriate risk management measures are implemented.

Effects on developmental toxicity

Effect on developmental toxicity: via oral route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

No reliable bioassays were located regarding developmental effects in humans or test animals after exposure to 4,4´-methylenedianiline by any route of exposure. A single study in rats showed that exposure to 4,4´-methylenedianiline during gestation may result in adverse developmental effects (Bourdelat et al. 1983). The study, however, was of limited scope and was not well conducted. A study of uncertain relevance reports that MDA injected into the yolks of fertile eggs reduces hatching frequency and has teratogenic effects (McLaughlin, J., et al, 1963).

According to regulation 1907/2006/EC, annex 10, section 8.7 developmental studies are not required as MDA is a genotoxic carcinogen and appropriate risk management measures are implemented.

Justification for classification or non-classification

Not applicable, since according to regulation 1907/2006/EC, annex 10, section 8.7 studies on reproductive toxicity are not required as MDA is considered as a genotoxic carcinogen and appropriate risk management measures are implemented.

Additional information